Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of ADMA BIOLOGICS, INC. from 31 Mar 2024 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
ADMA BIOLOGICS, INC. quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD history and change rate from 31 Mar 2024 to 31 Mar 2025.
  • ADMA BIOLOGICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending 31 Mar 2025 was $373,419,000, a 143% increase year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

ADMA BIOLOGICS, INC. Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $373,419,000 +$219,713,000 +143% 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $153,706,000 31 Mar 2024 10-Q 07 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.